← ANALYST RATINGS · TIPRANKS
Wave Life Sciences (WVE): analyst forecast and price target
Analyst consensus
Strong Buy15 Buy1 Hold0 Sell
Ratings of 16 analysts in the last 3 months12-month forecast
Based on 16 price targets given in the last 3 months, the average target is $18.74, the highest $42.00, the lowest $8.37. The average is +498.7% from the last price of $3.13.
Analyst ratings 21
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Sharon Zackfia★★★★★★★★★★#4054 · hits 44% · avg +3.0% | William Blair | $8.37 | Buy | +167.4% | Initiated | 15.10.26on TipRanks Oct 16 05:55 | +3.0%next day −0.8% | ↗ |
| Unknown Analyst | UBS | $11.00 | Buy | +251.4% | Initiated | 15.10.26on TipRanks 16:05 | −0.8% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $3.50 → $3.00−14.3% | Hold | −4.2% | Reiterated | 14.10.26on TipRanks 10:06 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $3.50 → $3.00−14.3% | Hold | −4.2% | Reiterated | 14.10.26on TipRanks 10:06 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $3.50 → $3.00−14.3% | Hold | −4.2% | Reiterated | 14.10.26on TipRanks 10:06 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $3.50 → $3.00−14.3% | Hold | −4.2% | Reiterated | 13.10.26on TipRanks 04:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $3.50 → $3.00−14.3% | Sell | −4.2% | Downgrade | 13.10.26on TipRanks 04:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $3.50 → $3.00−14.3% | Hold | −4.2% | Reiterated | 13.10.26on TipRanks 04:05 | — | |
| Madison Elsaadi★★★★★★★★★★#984 · hits 54% · avg +35.6% | B. Riley Securities | $22.00 | Buy | +602.9% | Reiterated | 12.10.26on TipRanks 09:10 | −5.1%next day −4.3% | ↗ |
| Whitney Ijem★★★★★★★★★★#537 · hits 48% · avg +20.2% | Canaccord Genuity | $42.00 | Buy | +1,241.9% | Reiterated | 05.10.26on TipRanks Oct 7 04:15 | −1.5%next day −6.7% · 5 days −13.0% | ↗ |
| Danielle Brill★★★★★★★★★★#566 · hits 56% · avg +16.1% | Truist Financial | — | Buy | — | Reiterated | 02.10.26on TipRanks 07:35 | −3.3%next day −1.5% · 5 days −9.6% | ↗ |
| Andrew Fein★★★★★★★★★★#267 · hits 52% · avg +23.7% | H.C. Wainwright | $13.00 | Buy | +315.3% | Reiterated | 02.10.26on TipRanks 06:55 | −3.3%next day −1.5% · 5 days −9.6% | ↗ |
| Alec Stranahan★★★★★★★★★★#1533 · hits 52% · avg +8.4% | Bank of America Securities | $17.00 | Buy | +443.1% | Reiterated | 01.10.26on TipRanks Oct 2 05:10 | +4.7%next day −3.3% · 5 days −11.9% | ↗ |
| Rick Bienkowski★★★★★★★★★★#12090 · hits 19% · avg −23.3% | Ladenburg Thalmann & Co. | $10.00 | Buy | +219.5% | Initiated | 01.10.26on TipRanks 06:55 | +4.7%next day −3.3% · 5 days −11.9% | ↗ |
| Yun Zhong★★★★★★★★★★#12228 · hits 38% · avg −9.6% | Wedbush | $12.00 | Buy | +283.4% | Reiterated | 30.09.26on TipRanks 13:15 | +1.9%next day +4.7% · 5 days −6.2% | ↗ |
| Tessa Romero★★★★★★★★★★#805 · hits 57% · avg +21.7% | J.P. Morgan | — | Hold | — | Downgrade | 23.09.26on TipRanks 07:55 | −8.5%next day +0.3% · 5 days −5.7% | ↗ |
| Benjamin Burnett★★★★★★★★★★#5339 · hits 45% · avg +1.7% | Wells Fargo | $14.00 | Buy | +347.3% | Reiterated | 09.09.26on TipRanks Sep 10 05:31 | −1.6%next day −2.3% · 5 days −5.2% | ↗ |
| Catherine Novack★★★★★★★★★★#905 · hits 41% · avg +25.1% | JonesTrading | $30.00 | Buy | +858.5% | Reiterated | 07.08.26on TipRanks Sep 27 18:06 | +0.7%next day −0.5% · 5 days −11.7% | |
| Salim Syed★★★★★★★★★★#7609 · hits 44% · avg +0.2% | Mizuho Securities | $27.00 → $23.00−14.8% | Buy | +634.8% | Reiterated | 03.08.26on TipRanks 11:30 | +2.8%next day +2.7% · 5 days +3.7% | ↗ |
| Mara Goldstein★★★★★★★★★★#12071 · hits 34% · avg −5.0% | Mizuho Securities | $36.00 → $26.00−27.8% | Buy | +730.7% | Reiterated | 03.08.26on TipRanks Jul 30 18:40 | −5.1%next day +2.8% · 5 days +7.2% | ↗ |
| Samantha Semenkow★★★★★★★★★★#6889 · hits 47% · avg +0.7% | Citi | $24.00 → $19.00−20.8% | Buy | +507.0% | Reiterated | 31.07.26on TipRanks 06:55 | −5.1%next day +2.8% · 5 days +7.2% | ↗ |
| Luca Issi★★★★★★★★★★#11187 · hits 39% · avg −2.1% | RBC Capital | $15.00 | Buy | +379.2% | Reiterated | 30.07.26on TipRanks Jul 31 10:36 | −2.5%next day −5.1% · 5 days +0.9% | ↗ |
| Steven Seedhouse★★★★★★★★★★#1374 · hits 43% · avg +10.3% | Cantor Fitzgerald | $13.00 | Buy | +315.3% | Reiterated | 18.05.26on TipRanks May 19 07:50 | −5.4%next day −3.4% · 5 days −1.9% | ↗ |
| Roger Song★★★★★★★★★★#4779 · hits 41% · avg +2.6% | Jefferies | $28.00 → $18.00−35.7% | Buy | +475.1% | Assigned | 26.03.26on TipRanks 14:15 | −47.8%next day +4.4% · 5 days +15.8% | ↗ |
| Joseph Schwartz★★★★★★★★★★#135 · hits 54% · avg +31.9% | Leerink Partners | $35.00 → $25.00−28.6% | Buy | +698.7% | Reiterated | 26.03.26on TipRanks 09:10 | −47.8%next day +4.4% · 5 days +15.8% | ↗ |
| Cheng Li★★★★★★★★★★#11750 · hits 22% · avg −28.7% | Oppenheimer | $32.00 | Buy | +922.4% | Reiterated | 27.02.26on TipRanks Mar 2 12:55 | −8.8%next day −0.6% · 5 days −3.8% | ↗ |
| Martin Auster★★★★★★★★★★#1128 · hits 51% · avg +16.1% | Raymond James | $13.87 → $26.00+87.5% | Buy | +730.7% | Reiterated | 13.01.26on TipRanks 05:20 | +2.4%next day +2.5% · 5 days −0.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Wave Life Sciences
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $18.00 at a price of $3.70 (+386.5%); now: $18.74 at $3.13 (+498.7%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 34 | 22 | 19 | 14 | 16 | 15 |
| Buy | 1 | 1 | 1 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.33 (from $-0.38 to $-0.25). Last quarter: $-0.34.
Sales
Next quarter’s sales estimate — $5M (from $0M to $20M). Last quarter: $2M.
Best top-analyst consensus in the sector · Healthcare
About Wave Life Sciences
- CEO: Paul Bolno
- Employees: 317
- 733 Concord Avenue, Cambridge, MA, 02138, US
- wavelifesciences.com
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-008, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of liver disease; WVE-N531, an exon splicing oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington’s disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Data from the stock’s TipRanks forecast page, read 50 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗